Status:
COMPLETED
Quantra QPlus Sample Type Comparison
Lead Sponsor:
HemoSonics LLC
Conditions:
Coagulation Defect; Bleeding
Eligibility:
All Genders
18+ years
Brief Summary
This is a single center prospective observational study to compare QPlus parameter measurements in arterial and venous blood samples collected in parallel from patients undergoing cardiac surgery.
Detailed Description
In this single center prospective observational study, 40 cardiac surgery subjects will enrolled, each with parallel artrial and venous samples collected at 3 time points to yield 120 matched samples ...
Eligibility Criteria
Inclusion
- Subject is scheduled for cardiac surgery, utilizing cardiopulmonary bypass, or including placement of a ventricular assist device
- Subject is ≥18 years
- Subject or subject's legally authorized representative is willing to participate and he/she has signed a consent formr.
Exclusion
- Subject is younger than 18 years
- Subject is pregnant
- Subject is incarcerated at the time of the study
- Subject is affected by a condition that, in the opinion of the surgical team, may pose additional risks
- Subject, or subject's legally aurthorized representative is able to provide written informed consent
Key Trial Info
Start Date :
November 4 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 2 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05290675
Start Date
November 4 2021
End Date
November 2 2022
Last Update
May 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ohio State University Wexner Medical Center
Columbus, Ohio, United States, 43210